AGEN Insider Transactions
155 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
AGEN insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| ARMEN GARO H | See Remarks | 2024-02-15 | Purchase | 500,000.0 | $0.65 |
| WIINBERG ULF | Director | 2023-11-15 | Purchase | 25,000.0 | $0.76 |
| O'Day Steven J | Chief Medical Officer | 2022-01-06 | Sale | 38,679.0 | $3.06 |
| ARMEN GARO H | Chairman and CEO | 2021-09-13 | Sale | 82,107.0 | $6.5 |
| KLASKIN CHRISTINE M | PFO & PAO | 2021-09-10 | Sale | 11,120.0 | $6.5 |
| INCYTE CORP | TenPercentOwner | 2020-06-17 | Sale | 141,920.0 | $3.66 |
| INCYTE CORP | TenPercentOwner | 2020-06-16 | Sale | 72,080.0 | $3.66 |
| INCYTE CORP | TenPercentOwner | 2020-06-15 | Sale | 384,025.0 | $3.57 |
| INCYTE CORP | TenPercentOwner | 2020-06-12 | Sale | 9,100.0 | $3.58 |
| INCYTE CORP | TenPercentOwner | 2020-06-11 | Sale | 183,875.0 | $3.77 |
| Baysal Ozer | Chief Commercial Officer | 2017-12-12 | Sale | 3,712.0 | $3.46 |
| Buell Jennifer | Chief Communications Officer | 2017-12-12 | Sale | 3,511.0 | $3.46 |
| Duncan Alex | Chief Technology Officer | 2017-12-12 | Sale | 6,546.0 | $3.46 |
| KLASKIN CHRISTINE M | VP, Finance | 2017-12-12 | Sale | 5,610.0 | $3.46 |
| Valentine Karen | Chief Legal Officer | 2017-12-12 | Sale | 8,358.0 | $3.46 |
| ARMEN GARO H | Chairman & CEO | 2017-10-30 | Purchase | 40,388.0 | $3.61 |
| ARMEN GARO H | Chairman & CEO | 2017-10-27 | Purchase | 59,612.0 | $3.51 |
| ARMEN GARO H | Chairman & CEO | 2017-04-12 | Purchase | 29,456.0 | $3.29 |
| ARMEN GARO H | Chairman & CEO | 2017-04-10 | Purchase | 70,544.0 | $3.37 |
| INCYTE CORP | TenPercentOwner | 2017-02-14 | Purchase | 10,000,000.0 | $6.0 |
| WIINBERG ULF | Director | 2016-09-06 | Purchase | 30,000.0 | $6.29 |
| ARMEN GARO H | Chairman & CEO | 2016-05-09 | Purchase | 50,000.0 | $3.28 |
| ARMEN GARO H | Chairman & CEO | 2016-05-09 | Purchase | 50,000.0 | $3.28 |
| ARMEN GARO H | Chairman & CEO | 2016-05-06 | Purchase | 50,000.0 | $3.08 |
| ARMEN GARO H | Chairman & CEO | 2016-05-05 | Purchase | 50,000.0 | $3.08 |
| Baysal Ozer | Chief Business Officer | 2016-05-05 | Purchase | 2,250.0 | $3.1 |
| ARMEN GARO H | Chairman & CEO | 2016-03-07 | Purchase | 200,000.0 | $4.03 |
| ARMEN GARO H | Chairman & CEO | 2015-12-29 | Sale | 85,224.0 | $4.57 |
| ARMEN GARO H | Chairman & CEO | 2015-12-28 | Sale | 89,917.0 | $4.59 |
| ARMEN GARO H | Chairman & CEO | 2015-12-28 | Sale | 44,435.0 | $4.62 |
| ARMEN GARO H | Chairman & CEO | 2015-09-25 | Purchase | 100,000.0 | $5.03 |
| Ballantyne Charles Evan | Chief Financial Officer | 2015-09-25 | Purchase | 10,000.0 | $5.05 |
| Malik Shahzad | Director | 2015-04-29 | Sale | 407,377.0 | $7.02 |
| Malik Shahzad | Director | 2015-04-28 | Sale | 700,000.0 | $7.16 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 41,830.0 | $5.33 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 41,830.0 | $5.33 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 83,100.0 | $5.31 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 83,100.0 | $5.31 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 100,000.0 | $5.35 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 100,000.0 | $5.35 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 89,800.0 | $5.49 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 89,800.0 | $5.49 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 50,000.0 | $5.44 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 50,000.0 | $5.44 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 100,000.0 | $5.2 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 100,000.0 | $5.2 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 43,080.0 | $5.57 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 43,080.0 | $5.57 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 856,920.0 | $5.18 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 856,920.0 | $5.18 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 215,000.0 | $5.19 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 215,000.0 | $5.19 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 400,000.0 | $5.62 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 400,000.0 | $5.62 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 53,606.0 | $5.21 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 53,606.0 | $5.21 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 146,394.0 | $5.27 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 146,394.0 | $5.27 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 143,900.0 | $5.3 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 143,900.0 | $5.3 |
| QVT Associates GP LLC | TenPercentOwner | 2015-01-09 | Sale | 20,000.0 | $5.55 |
| QVT Fund V LP | TenPercentOwner | 2015-01-09 | Sale | 20,000.0 | $5.55 |
| Wentworth Kerry | VP, Clinical, Reg & Qual | 2014-02-26 | Sale | 5,000.0 | $5.0 |
| Valentine Karen | VP General Counsel | 2014-01-23 | Sale | 2,850.0 | $3.5 |
| Sharp Shalini | Director | 2013-01-30 | Sale | 288.0 | $4.36 |
| Sharp Shalini | Director | 2012-10-31 | Sale | 288.0 | $4.4 |
| Sharp Shalini | Director | 2012-08-29 | Sale | 288.0 | $4.64 |
| Wentworth Kerry | VP, Clinical, Reg, & Quality | 2011-12-29 | Sale | 8,939.0 | $2.01 |
| Valentine Karen | VP, General Counsel | 2011-12-29 | Sale | 7,605.0 | $1.98 |
| KLASKIN CHRISTINE M | VP, Finance | 2011-12-29 | Sale | 6,391.0 | $2.0 |
| KLASKIN CHRISTINE M | VP, Finance | 2011-12-29 | Sale | 6,391.0 | $2.0 |
| Wentworth Kerry | VP, Clinical, Reg, & Quality | 2011-12-28 | Sale | 1,893.0 | $2.09 |
| Valentine Karen | VP, General Counsel | 2011-12-28 | Sale | 1,301.0 | $2.09 |
| KLASKIN CHRISTINE M | VP, Finance | 2011-12-28 | Sale | 1,095.0 | $2.09 |
| Sharp Shalini | CFO | 2011-12-28 | Sale | 1,711.0 | $2.09 |
| KLASKIN CHRISTINE M | VP, Finance | 2011-12-28 | Sale | 1,095.0 | $2.09 |
| Wentworth Kerry | VP, Clinical, Reg, & Quality | 2011-12-27 | Sale | 3,156.0 | $2.14 |
| Valentine Karen | VP, General Counsel | 2011-12-27 | Sale | 2,169.0 | $2.14 |
| KLASKIN CHRISTINE M | VP, Finance | 2011-12-27 | Sale | 1,824.0 | $2.14 |
| Sharp Shalini | CFO | 2011-12-27 | Sale | 2,853.0 | $2.14 |
| KLASKIN CHRISTINE M | VP, Finance | 2011-12-27 | Sale | 1,824.0 | $2.14 |
| Wentworth Kerry | VP, Clinical, Reg, & Quality | 2011-12-23 | Sale | 886.0 | $2.2 |
| Valentine Karen | VP, General Counsel | 2011-12-23 | Sale | 608.0 | $2.2 |
| Sharp Shalini | CFO | 2011-12-23 | Sale | 795.0 | $2.2 |
| KLASKIN CHRISTINE M | VP Finance | 2011-12-23 | Sale | 511.0 | $2.2 |
| Wentworth Kerry | VP, Clinical, Reg, & Quality | 2011-12-22 | Sale | 1,716.0 | $2.19 |
| Valentine Karen | VP, General Counsel | 2011-12-22 | Sale | 1,177.0 | $2.19 |
| Sharp Shalini | CFO | 2011-12-22 | Sale | 1,548.0 | $2.19 |
| KLASKIN CHRISTINE M | VP Finance | 2011-12-22 | Sale | 993.0 | $2.19 |
| Wentworth Kerry | VP, Clinical, Reg, & Quality | 2011-12-21 | Sale | 3,414.0 | $2.24 |
| Valentine Karen | VP, General Counsel | 2011-12-21 | Sale | 2,348.0 | $2.24 |
| Sharp Shalini | CFO | 2011-12-21 | Sale | 3,087.0 | $2.24 |
| KLASKIN CHRISTINE M | VP Finance | 2011-12-21 | Sale | 1,975.0 | $2.24 |
| ARMEN GARO H | Chairman & CEO | 2011-09-30 | Purchase | 16,666.0 | $2.99 |
| ARMEN GARO H | Chairman & CEO | 2011-08-16 | Purchase | 2,150,976.0 | $0.51 |
| Sharp Shalini | CFO | 2010-10-28 | Sale | 1,500.0 | $0.96 |
| Valentine Karen | VP and General Counsel | 2010-10-27 | Sale | 2,500.0 | $0.98 |
| Wentworth Kerry | VP, Clin, Reg & Quality | 2010-10-26 | Sale | 4,165.0 | $0.97 |
| KLASKIN CHRISTINE M | VP, Finance | 2010-10-26 | Sale | 2,500.0 | $0.97 |
| Wentworth Kerry | Vp, Clin, Reg & Quality | 2010-09-14 | Sale | 1,453.0 | $0.91 |